PRKDC and cancer: Our study indicates that while partial DNA-PK inhibition has a modest impact on the viability of p53-proficient cells after radiomimetic treatment, it potently stimulates cell death via mitotic catastrophe in p53-deficient cells, as has recently also been demonstrated in a panel of human cancer cell lines (62).